CLDN10 and cancer: Surprisingly, CLDN10 was overexpressed in cancer, but patients with high expression of CLDN10 showed good OS (HR = 0.73, logrank P = 1.6e-06), PFS (HR = 0.83, logrank P = 0.0067), and post progression survival (PPS, HR = 0.73, logrank P = 0.00029).